Care Access, a decentralized clinical trials delivery company, agreed to acquire Instituto Brasil de Pesquisa Clínica, a clinical trial company. Financial terms were not disclosed. “We’re on a path to achieve dramatically better and faster results for global clinical trials, with the intention to accelerate the approval process of new therapies and to bring more treatment options to healthcare. Our mission is to bring to life the future of clinical research, and IBPClin shares our vision to bring our unique DCT model to Latin America. A motivated world-class team, with the right level of support and the right resources, can make a dramatic impact – we look forward to seeing the fruits of this labor in the coming year,” Ahmad Namvargolian, Care Access CEO and Co-Founder.